South San Francisco 409A Valuations Lawyer

When the IRS turns its attention to deferred compensation arrangements, it does not begin by looking at the documents a company prepared after the fact. It begins by asking whether the company got a defensible, independent valuation before options were granted. That sequencing matters enormously. Companies that treated 409A valuations as a compliance checkbox rather than a strategic legal and financial exercise often discover, during audits or acquisition due diligence, that their options were priced below fair market value, triggering significant tax penalties for employees and liability exposure for leadership. Working with a South San Francisco 409A valuations lawyer before those issues surface is how founders and executives keep a valuation problem from becoming a company-ending problem.

What Section 409A Actually Does and Why It Matters More Than Most Founders Think

Section 409A of the Internal Revenue Code governs nonqualified deferred compensation, and stock options granted with an exercise price below fair market value fall squarely within its reach. When options are granted at a strike price lower than the company’s true fair market value on the grant date, the IRS treats the discount as deferred compensation. The employee faces immediate income recognition in the year the option vests, a 20 percent excise tax on top of ordinary income rates, and potential interest charges. In high-growth environments where option values can appreciate sharply in a short period, the resulting tax exposure can be substantial, sometimes rendering the option economically worthless to the person who received it.

What makes 409A issues particularly dangerous is how they compound. A flawed valuation does not just hurt the employee who receives the option. It creates liability for the company that issued it, disrupts financing rounds when investors conduct due diligence, and can derail acquisition conversations when a buyer’s counsel identifies improper grant pricing in the cap table. Companies in South San Francisco’s dense biotech and technology corridor often encounter this problem during Series A or Series B diligence, when the stakes are highest and the timeline to correct anything is shortest.

Qualified independent appraisals performed by a qualified appraiser, or certain internal valuations performed by companies with consistent methodologies, create a presumption of correctness that shifts the burden of proof back to the IRS. That presumption is worth building carefully and early. An attorney experienced in this area helps companies understand what constitutes a defensible valuation, when to refresh it, and how the timing of option grants interacts with material corporate events.

The Most Common 409A Mistakes Companies Make and How to Avoid Them

The most frequent mistake is treating the 409A valuation as a financial exercise entirely divorced from legal counsel. Founders often hire a valuation firm, receive a report, and file it away without examining whether the methodology accounts for recent financing terms, option pool expansion, secondary transactions, or other events that would affect fair market value. The result is a report that appears compliant on its surface but cannot withstand scrutiny because the inputs were incomplete or the timing was wrong.

A second common error is failing to refresh the valuation at the right intervals. A 409A appraisal is generally considered valid for twelve months, but it must be updated earlier if a material event occurs. Closing a new financing round, receiving a term sheet for an acquisition, issuing convertible instruments, or experiencing a significant change in the business all qualify as triggering events that require a fresh valuation before additional options are granted. Companies that continue granting options on a stale valuation because “we just did this last year” create a growing pool of potentially defective grants.

A third mistake, and one that catches many growth-stage companies off guard, is mishandling the valuation in connection with secondary transactions. When employees or early investors sell shares in a secondary market transaction, that transaction can serve as evidence of fair market value. If the company’s 409A valuation is materially inconsistent with the pricing of a recent secondary sale, the IRS has ammunition to challenge the valuation’s defensibility. Coordinating the timing and documentation of secondary transactions with an understanding of their 409A implications is exactly the kind of issue that benefits from early legal involvement.

How Legal Counsel Shapes the 409A Process From the Start

A lawyer working alongside the valuation firm adds a dimension that financial analysts alone cannot provide. The legal perspective addresses how valuation inputs align with the company’s existing agreements, how recent corporate events should be characterized and disclosed, and whether the documentation supporting the valuation would hold up to IRS review or litigation. This is not theoretical oversight. It is practical deal work applied to a compliance context.

At Triumph Law, the approach to 409A matters reflects the firm’s broader philosophy: experienced transactional counsel that understands how legal decisions intersect with business realities. The attorneys at Triumph Law draw from backgrounds at major law firms and in-house legal departments, which means they understand what institutional investors and acquiring companies look for during diligence. They also understand that founders and executives need guidance that is direct and actionable, not layered in unnecessary qualification.

For companies in South San Francisco’s life sciences and technology sectors, this means working with counsel that understands the specific valuation challenges that arise in those industries. Biotech companies face distinct issues around milestone-based value drivers and the treatment of intellectual property in a pre-revenue context. Software and SaaS companies face different questions around ARR multiples, market comparables, and how investor rights provisions affect common stock value. Legal counsel that understands these sector-specific dynamics helps ensure that the valuation methodology actually fits the company’s situation.

409A Valuations in the Context of Financing and Acquisition Transactions

The stakes around 409A compliance rise sharply when a company enters a financing or acquisition process. Investors and acquirers conducting due diligence will scrutinize option grant pricing, review all existing 409A reports, and assess whether the company’s historical grants were properly timed relative to material events. Defective grants discovered during diligence create negotiating leverage for the other side and can reduce a company’s valuation or lead to escrow holdbacks structured around potential tax liability exposure.

For companies raising venture capital in the competitive South San Francisco market, arriving at a financing with a clean, defensible 409A history signals operational maturity and management discipline. Investors notice when companies have been proactive about this. They also notice when companies have not. A disorganized or indefensible 409A record raises broader questions about how the founders are managing other legal and financial obligations.

Triumph Law represents both companies and investors in funding transactions, which provides the firm’s attorneys with insight into what institutional venture funds actually examine during diligence. That perspective informs how the firm advises companies on 409A compliance, not just as a tax matter, but as a transaction readiness matter that affects how deals close and at what terms.

An Unexpected Angle: Why Employees Should Care as Much as Founders

Employees who receive stock options rarely think about 409A compliance as their issue to worry about. They sign the grant agreement, track the vesting schedule, and wait. But the penalties for a defective grant fall primarily on the employee, not the company. If options were granted at a price below fair market value due to a flawed or missing valuation, the employee faces the income recognition and excise tax exposure, often years after the grant was made and without any warning. This is one of the more counterintuitive features of 409A compliance: the compliance failure originates with the company, but the financial consequences land on the individual.

Employees considering joining an early-stage company, or those negotiating updated option grants at an established company, benefit from understanding the basics of whether the company has maintained current and defensible 409A valuations. An attorney can review existing grant documentation and flag potential issues before an employee is locked into terms they did not fully understand.

South San Francisco 409A Valuations FAQs

When does a company need to obtain a new 409A valuation?

A 409A valuation is generally valid for twelve months from the date of the appraisal, or until a material event occurs, whichever comes first. Material events include closing a new financing round, signing a letter of intent for an acquisition, issuing new convertible instruments, or any other development that would significantly affect the company’s fair market value. Companies should obtain a fresh valuation before granting additional options after any of these events, regardless of when the last appraisal was completed.

Can a company perform its own 409A valuation internally?

Yes, but only under specific conditions. A company may perform an internal valuation if it has illiquid equity, has been in existence for less than ten years, and the valuation is performed by someone with significant knowledge and experience in business valuations. As a practical matter, most companies in growth stages rely on independent third-party appraisers because the presumption of correctness is far stronger when an independent qualified appraiser prepares the report, reducing the risk of IRS challenge.

What happens if option grants are found to violate Section 409A during an acquisition?

Defective grants discovered during M&A diligence can result in deal price reductions, indemnification provisions, or escrow holdbacks. The acquirer may also require the company to take corrective action before closing, which can delay or complicate the transaction. In some cases, the parties negotiate a mechanism to compensate affected employees for the tax burden they will face, which effectively increases the company’s cost of the transaction. Early legal attention to 409A compliance is one of the most cost-effective steps a company can take in preparing for a sale.

How does preferred stock financing affect the 409A valuation of common stock?

Preferred stock carries rights and preferences that common stock does not, including liquidation preferences, anti-dilution protections, and conversion features. These differences mean that common stock is typically worth less than preferred stock on a per-share basis. The 409A valuation uses methodologies such as the option pricing model or probability-weighted expected return method to allocate value between share classes and arrive at a defensible fair market value for common stock. The more complex the capital structure, the more judgment-intensive the analysis becomes.

Does Triumph Law work with companies outside the Washington DC area?

Triumph Law’s transactional practice regularly supports national and international deals, and the firm advises clients across technology and startup ecosystems beyond the DC metro region. Companies in high-growth markets like South San Francisco can engage Triumph Law for strategic corporate and technology transactional counsel, including guidance on equity compensation structures and 409A-related legal matters.

How does a 409A valuation interact with equity incentive plan design?

The equity incentive plan and the 409A valuation work together. The plan sets the framework for how options are authorized and granted, while the valuation establishes the exercise price at which options must be set to avoid deferred compensation treatment. Attorneys who help design or review equity incentive plans should also be considering the timing and frequency of valuations, the handling of plan amendments, and how changes in the option pool affect dilution calculations that feed into the valuation methodology.

Serving Throughout South San Francisco

Triumph Law serves clients throughout the South San Francisco area, including the biotech and life sciences corridor along East Grand Avenue and Oyster Point, as well as companies based in nearby Brisbane, Burlingame, San Mateo, and Millbrae. The firm also works with clients operating in the broader Peninsula, including Redwood City, Menlo Park, and Palo Alto, where startup activity and venture capital investment remain highly concentrated. Founders and executives working out of the South San Francisco Innovation Zone, one of the most recognizable clusters of biotech headquarters in the country, often have equity compensation questions that require both legal precision and an understanding of how high-growth science and technology companies are structured and funded. Whether a company is based in the heart of the SoMa district to the north or operates from a research campus adjacent to San Francisco International Airport, Triumph Law provides transactional legal counsel that aligns with the pace and complexity of the industries driving this region’s economy.

Contact a South San Francisco 409A Valuations Attorney Today

Equity compensation structures that are built on a solid legal and financial foundation give companies a meaningful advantage at every stage of growth. Whether you are preparing for a seed round, managing ongoing option grants, or approaching an acquisition, having a South San Francisco 409A valuations attorney in your corner before a problem surfaces is far better than trying to repair one afterward. Triumph Law offers the transactional depth of a large firm and the responsiveness of a boutique built for founders and high-growth companies. Reach out to our team to schedule a consultation and start building the kind of legal foundation your company deserves.